Abstract

Dr. Albert Bruce Sabin, a Polish-American virologist, transformed global public health through the development of the oral polio vaccine (OPV), a breakthrough that played a pivotal role in the near-eradication of poliomyelitis worldwide. Born in 1906 and shaped by early experiences of poverty, migration, and disease, Sabin devoted his career to understanding and preventing infectious illnesses affecting children. Unlike Jonas Salk’s injectable inactivated vaccine, Sabin’s live attenuated oral vaccine induced strong intestinal immunity, effectively halting viral transmission and enabling large-scale immunization campaigns, especially in low-resource regions. Despite scientific rivalries, political challenges, and Cold War barriers, Sabin persisted and conducted crucial field trials internationally, including in the Soviet Union. His decision not to patent the OPV reflected his deep humanitarian commitment, ensuring global accessibility. Sabin’s legacy is defined not only by scientific brilliance but by ethical leadership, resilience, and lifelong dedication to protecting children’s health across the world. Key Messages: Dr. Albert Bruce Sabin revolutionized global public health by developing the oral polio vaccine (OPV), a safe, low-cost, easily administered vaccine that protected millions of children worldwide and dramatically reduced polio transmission. His selfless decision to not patent the vaccine ensured universal accessibility, demonstrating that scientific innovation coupled with humanitarian ethics can transform global child health.

• 1.   Let passion guide your path – Sabin started in dentistry but found his calling in virology. Following one’s true interests can lead to meaningful work.
• 2.   Serve others with science – His commitment to using science for the betterment of children’s health across the world exemplifies true humanitarian spirit.
• 3.   Be ethically grounded – Refusing to patent the vaccine showed that ethics and compassion should guide professional decisions.
• 4.   Persistence pays off – Despite obstacles, rivalries, and delays, Sabin continued working on what he believed was a better solution for polio. His persistence paid off not just for him, but for the world.
• 5.   Global collaboration matters – Working with scientists from different countries, even during times of political tension, helped Sabin demonstrate that science transcends borders.
• 6.   Sabin Albert B. Live, orally given poliovirus vaccine. Journal of the American Medical Association 1957; 164(11): 1216-1223.
• 7.   Sabin Albert B. Present status of attenuated live-virus poliomyelitis vaccine. Bulletin of the World Health Organization 1955; 13(3): 381-393.
• 8.   Plotkin Stanley A., Vidor Edmond. Poliovirus vaccine – Inactivated and live. Vaccines 2008; 5(1): 605-629.
• 9.   Nathanson Neal, Kew Olen M. From emergence to eradication: The epidemiology of poliomyelitis. American Journal of Epidemiology 2010; 172(11): 1213-1229.
• 10.   Minor Philip D. The polio-eradication programme and issues of the end game. Journal of General Virology 2012; 93(3): 457-474.

Data Sharing Statement

Funding